Tandem Diabetes Care (TNDM) Inventory Average (2014 - 2026)

Tandem Diabetes Care (TNDM) has reported Inventory Average for 13 consecutive years, with $130.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory Average fell 7.84% year-over-year to $130.8 million; the trailing twelve-month figure through Jun 2026 stood at $130.8 million (down 7.84% YoY), and the FY2025 full-year result was $139.2 million, down 9.48% from the prior year.
• Inventory Average rose to $130.8 million in Q2 2026 per TNDM's latest filing, from $127.6 million in the prior quarter.
• Across five years, Inventory Average topped out at $157.8 million in Q2 2024 and bottomed at $74.3 million in Q1 2022.
• Historically, Inventory Average has averaged $131.1 million across 5 years, with a median of $139.8 million in 2023.
• The sharpest annual moves came in 2023 and 2026: Inventory Average jumped 66.08% in 2023, then slipped 12.25% in 2026.
• Over 5 years, Inventory Average stood at $107.9 million in 2022, then surged by 39.62% to $150.7 million in 2023, then increased by 0.21% to $151.0 million in 2024, then retreated by 11.92% to $133.0 million in 2025, then decreased by 1.71% to $130.8 million in 2026.
• According to Business Quant data, Inventory Average over the past three periods registered $130.8 million, $127.6 million, and $133.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.